The SafeBoosC phase II clinical trial: an analysis of the interventions related with the oximeter readings

BACKGROUND: The SafeBoosC phase II randomised clinical trial recently demonstrated the benefits of a combination of cerebral regional tissue oxygen saturation (rStO(2)) by near-infrared spectroscopy (NIRS) and a treatment guideline to reduce the oxygen imbalance in extremely preterm infants. AIMS: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Riera, Joan, Hyttel-Sorensen, Simon, Bravo, María Carmen, Cabañas, Fernando, López-Ortego, Paloma, Sanchez, Laura, Ybarra, Marta, Dempsey, Eugene, Greisen, Gorm, Austin, Topun, Claris, Olivier, Fumagalli, Monica, Gluud, Christian, Lemmers, Petra, Pichler, Gerhard, Plomgaard, Anne Mette, van Bel, Frank, Wolf, Martin, Pellicer, Adelina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941140/
https://www.ncbi.nlm.nih.gov/pubmed/26645538
http://dx.doi.org/10.1136/archdischild-2015-308829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941140/
https://www.ncbi.nlm.nih.gov/pubmed/26645538
http://dx.doi.org/10.1136/archdischild-2015-308829

Ejemplares similares